The average one-year price target for Werewolf Therapeutics (NasdaqGS:HOWL) has been revised to $5.30 / share. This is a decrease of 10.86% from the prior estimate of $5.95 dated December 18, 2025.
I visited an Illinois wolf sanctuary where the howls stop you cold. Real rescues, quiet moments, and a visit that lingers long after—with wolves.
Werewolf Therapeutics, Inc. (NASDAQ:HOWL) is included on our list of stocks under $1 that will explode. On December 18, 2025, Werewolf Therapeutics, Inc. (NASDAQ:HOWL) shared a comprehensive pipeline ...
This time of year, the sound of a wolf howl piercing the night can really send shivers up your spine. But that call of the wild isn’t meant to scare you; it’s actually a message to other wolves.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results